Lab Information
Emily McDonald (MD/MSc)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Quality improvement • patient safety • infectionResearch Interests
My research focuses on interventions related to polypharmacy, safe and effective prescribing, and medication rationalization. A number of my studies relating to the appropriate use of hospital resources, tests and investigations have been published in high impact peer-reviewed journals and several relating to safer prescribing in older adults were featured recently in the media. I supervise postgraduate students in the field of medication safety and have received funding from the CIHR, the Centre for Ageing and Brain Health Innovation, the Canadian Frailty Network and, locally, from the McGill Interdisciplinary Initiative in Infection and Immunity (MI-4).Team Members
| Name | Position |
|---|
Latest Publications
- Colmegna, I., Hudson, M., Biard, L., Azuelos, I., Davies, L., Hirsch, A., Leger, S., McDonald, E. G., Peltier, L., Popradi, G., Resche-Rigon, M., Robitaille, C., Svahn, M., Walter-Petrich, A., Martin, J. G. & Farge-Bancel, D. (2026). Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial. Cytotherapy, vol. 28, p. 102775.
- Prosty, C., Desormeau, B., Lee, T. C. & McDonald, E. G. (2026). Diagnosis, treatment, and prophylaxis of Clostridioides difficile infections: A cross-sectional survey of Canadian clinicians. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 11, p. 37-50.
- Ross, S. B., Bortolussi-Courval, É., Juhásová, Z., Weir, D. L., Wilson, A. G., Lee, T. C., McDonald, E. G. & Wilson, M. G. (2026). Measuring Medication Related Harm: Proposed Guidance for Adverse Drug Event Adjudication to Harmonize Outcomes in Deprescribing Research. Journal of the American Geriatrics Society.
- Butler, C. C., Pinto, A. D., Harris, V., Holmes, J., Rahman, N. M., Cureton, L., Hayward, G., Richards, D. B., Lowe, D. M., Standing, J. F., Breuer, J., Hood, K., Png, M. E., Petrou, S., Dorward, J., Patel, M. G., Thomas, N. P. B., Evans, P., Hart, N. D., Jani, B. D., Hosseini, B., Murthy, S., McBrien, K., Condon, A., McDonald, E. G., Daley, P., Greiver, M., da Costa, B. R., Selby, P., Jüni, P., Lee, T. C., Shi, H., Detry, M. A., Saunders, C. T., Fitzgerald, M., Berry, N. S., Saville, B. R., Khoo, S. H., Nguyen-Van-Tam, J. S., Hobbs, F. D. R., Yu, L.-M., Little, P. & PANORAMIC Trial and CanTreatCOVID Trial Collaborative Groups (2026). Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients. The New England journal of medicine, vol. 394, p. 1583-1594.
- Spellberg, B., Ghanem, B., Morante-Ruiz, M., Bortolussi-Courval, É., Makam, A. N., Ergenc, Z., Riccardi, N., Meyer-Sautter, P., Alharbi, S., Rocha-Pereira, N., Centor, R. M., Ryder, J., Bhoojhawon, G., Ahmed, I., Cabanilla, M. G., Almeida, F., Pimentel, B. V., Starkey, J., Costa, R. P. L., Maraolo, A. E., Tong, S. Y. C., Anderson, D. T., Murri, R., McDonald, E. G. & Lee, T. C. (2026). Evidence Over Eminence: Rethinking Specialty Guidelines Amid the ATS-IDSA Debate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
- Hosseini, B., Condon, A., da Costa, B. R., Daley, P., Greiver, M., Jüni, P., Lee, T. C., McBrien, K., McDonald, E. G., Murthy, S., Selby, P. & Pinto, A. D. (2026). Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID). Contemporary clinical trials, vol. 165, p. 108303.
- McDonald, E. G., Gagnon, M.-E., Jorgenson, D. J., Kraut, R. Y., Lee, J., Leung, L., Mangin, D., Marcoux, G., McCracken, R. K., Raman-Wilms, L., Sirois, C., Trimble, J., Young, J., Rizvi, A., Workentin, A. & Persaud, N. (2026). Screening for potentially inappropriate prescribing in primary care: Canadian guideline. Canadian family physician Medecin de famille canadien, vol. 72, p. 173-178.
- Ganmaa, D., Cook, K. A., Khudyakov, P., Enkhjargal, D., Bilegtsaikhan, T., Mayer, K. H., Clar, A., Rueschman, M., Balasubramanian, R., Hazra, A., Sesso, H. D., Stone, V. E., Copeland, P., Friedenberg, G., Smith, D. C., Lei, Q., Lee, T., McDonald, E. G., Enkhtsetseg, T., Sumiya, E., Narankhuu, Y., Erdenetuya, M., Tserendagva, D., Landberg, R., Roxhed, N., Lagerström, S. R. & Manson, J. E. (2026). A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 Trial. The Journal of nutrition, vol. 156, p. 101398.
- Yahav, D., Pinto, R., Cook, D., Davis, J., Duan, E., Hoffman, T., Lee, T. C., McDonald, E. G., Morpeth, S., Muscedere, J., Sligl, W., Wuerz, T., Fowler, R. A., Daneman, N. & BALANCE consortium (2026). Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
- McDonald, E. G., Butler-Laporte, G., Brophy, J. M., Elsayed, S., Frenette, C., Huseen, I., Loo, V. G., Moran, K., Coburn, B., Hota, S. S., Longtin, Y., Kong, L. Y., Muller, M. P., Steiner, T. S., Valiquette, L., Daneman, N., Daley, P., Nott, C., MacFadden, D. R., Kandel, C. E., Chen, Y., Perez-Patrigeon, S., Lee, T. C. & TAPER-V Team (2026). Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. JAMA network open, vol. 9, p. e2560495.
See also
